Sign In
Buy MNLO
$0.555
+0 (+0%)
At Close: Aug 17, 2022
Coronavirus throttles Metro teams' pursuits of national championships
10:43pm, Wednesday, 25'th Mar 2020
The Foothill-Pleasanton softball team and the baseball team from De La Salle-Concord were each among the favorites to finish their respective seasons No. 1 in the country. But now the players and coac
DZ Bank likes Medtronic in premarket analyst action
11:14am, Wednesday, 25'th Mar 2020
Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays.Molecular Templates (NASDAQ:MTEM) initiated with Buy rating and $19 (43% upside) price t
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
01:33pm, Friday, 13'th Mar 2020
The financial markets are tumbling, event cancellations are mounting, and sports leagues are suspending their seasons. March Madness is in full swing but
Goldman sees 143% upside in Amarin in premarket analyst action
11:26am, Friday, 13'th Mar 2020
IDEAYA Biosciences (NASDAQ:IDYA) initiated with Buy rating and $12 (192% upside) price target at Roth Capital.Menlo Therapeutics (NASDAQ:MNLO) resumed with Overweight rating and $15 (466% upside) at C
Analysts Are Bullish on These Healthcare Stocks: Lineage Cell Therapeutics (LCTX), Menlo Therapeutics (MNLO)
11:16am, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Cell Therapeutics (LCTX), Menlo Therapeutics (MNLO)
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Goldman adds Lilly to Conviction List in premarket analyst action
11:24am, Wednesday, 11'th Mar 2020
Menlo Therapeutics (NASDAQ:MNLO) initiated with Buy rating and $8 (113% upside) price target at Bank of America.Nutrien (NTR CN) initiated with Overweight rating and C$68.49 (47% upside) price target
Merger Arbitrage Mondays - Multiple 'Deals In The Works' Get Confirmed
01:21am, Wednesday, 11'th Mar 2020
Merger activity increased last week with four new deals announced. The acquisition of QIAGEN N.V. by Thermo Fisher Scientific for $11.5 billion. Genworth Financ
One new option listing and two option delistings on March 10th MNLO;FOMX;ZAYO
01:22pm, Tuesday, 10'th Mar 2020
One new option listing and two option delistings on March 10th MNLO FOMX ZAYO
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
12:37pm, Wednesday, 04'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) * Acceleron Pharma Inc (NASDAQ: XLRN) * BioMarin
SELLAS Positive Trial Data, And Other News: The Good, Bad And Ugly Of Biopharma
05:55pm, Saturday, 29'th Feb 2020
SELLAS announced positive data from a Leukemia trial. Endo declared upbeat earnings. Menlo's phase 2 trial fails to meet primary endpoint.
Cara Therapeutics: Scratching At Multiple Indications In 2020
05:54pm, Friday, 28'th Feb 2020
2020 is a big year for oral Korsuva. CARA took a big hit in late 2019 from oral phase 2 data. The second phase 3 readout for IV Korsuva, KALM-II, is set to repo
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More
02:52pm, Friday, 28'th Feb 2020
Clinical trials have historically hewn to a rigid format. A trial is designed, conducted according to that design, and then results are analyzed. Making
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viking Therapeutics (VKTX), Cyclacel Pharmaceuticals (CYCC)
